EXPERIENCE OF THE USE OF LEVOBUPIVACAINE FOR SPINAL ANESTHESIA IN UROLOGICAL INTERVENTIONS


Cite item

Full Text

Abstract

The prospective study included data obtained during the surgical treatment of 55 urological patients. In the X10 group (n = 25) for spinal anesthesia used 2 ml of a 0.5% isobaric solution of levobupivacaine (10 mg), in the X15 group (n = 30) - 3 ml of a similar solution (15 mg). Results. The time to the motor blockade of Bromage I in the study groups was 9 ± 3 min versus 8 ± 3 min, p = 0.154, to Bromage III - 18 ± 7 min versus 13 ± 3 min, p = 0.001. In group X10 motor blockade did not develop in 1, reached only the first degree - in 1, only the second degree - in 5 patients. In the X15 group, all patients underwent motor blockade of the third degree, except for 2 patients, in whom block reached only the second degree. The maximum level of sensory blockade in the group X10 was Th8, X15 - Th9. In the X10 group, the upper blockade level, not exceeding Th11, was observed in 11 (44%), and in the X15 group - in 17 (57%) patients. In 6 cases of the X10 group (24%) and 5 cases of the X15 group (17%) had to add sedation or general anesthesia. The duration of motor blockade before the beginning of recovery was 163 ± 57 min versus 195 ± 66 min, p = 0.076, until the motor block regressed completely - 219 ± 66 min versus 290 ± 90 min, p = 0.002. Arterial hypotension was observed in one patient group X10 (4%) and 0 group X15, bradycardia in 7 (28%) and 7 (23%) patients, respectively. There were no transient neurologic symptoms in any cases. Conclusions. Spinal anesthesia with isobaric levobupivacaine was characterized by a slow development of the complete motor block, unpredictably low upper level of the sensory blockade and a long-lasting motor block. It can be used in patients with high risk of arterial hypotension or transient neurologic symptoms, provided sufficient time is available before the operation, the possibility of sedation and / or the addition of general anesthesia.

About the authors

Roman V. Garyaev

N.N. Blokhin Russian Cancer Research Center

Email: romvga@mail.ru
MD, PhD, DSc, senior researcher of the department of anesthesiology, N.N. Blokhin Russian Cancer Research Center, 115478, Moscow, Russian Federation 115478, Moscow, Russian Federation

V. E Gruzdev

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

I. A Rychkov

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

References

  1. Bajwa S.J.S., Kaur J. Clinical profile of levobupivacaine in regional anesthesia: A systematic review. J. Anaesthesiol. Clin. Pharmacol. 2013; 29(4): 530-539.
  2. Burlacu C.L., Buggy D.J. Update on local anesthetics: focus on levobupivacaine. Ther. Clin. Risk Manag. 2008; 4(2): 381-392.
  3. Sell A., Olkkola K.T., Jalonen J., Aantaa R. Minimum effective local anaesthetic dose of isobaric levobupivacaine and ropivacaine administered via a spinal catheter for hip replacement surgery. Br. J. Anaesth. 2005; 94(2): 239-42.
  4. Parpaglioni R., Frigo M.G., Lemma A., Sebastiani M., Barbati G., Celleno D. Minimum local anaesthetic dose (MLAD) of intrathecal levobupivacaine and ropivacaine for Caesarean section. Anaesthesia. 2006; 61(2):110-5.
  5. Baydilek Y., Yurtlu B.S., Hanci V., Ayoğlu H., Okyay R.D., Kayhan G.E. et al. The comparison of levobupivacaine in continuous or single dose spinal anesthesia for transurethral resection of prostate surgery. Braz. J. Anesthesiol. 2014; 64(2): 89-97.
  6. Attri J.P., Kaur G., Kaur S., Kaur R., Mohan B., Kashyap K. Comparison of levobupivacaine and levobupivacaine with fentanyl in infraumbilical surgeries under spinal anaesthesia. Anesth. Essays Res. 2015; 9(2): 178-184.
  7. Vanna O., Chumsang L., Thongmee S. Levobupivacaine and bupivacaine in spinal anesthesia for transurethral endoscopic surgery. J. Med. Assoc. Thai. 2006; 89(8): 1133-9.
  8. Del-Rio-Vellosillo M., Garcia-Medina J.J., Abengochea-Cotaina A., Pinazo-Duran M.D., Barbera-Alacreu M. Spinal Anesthesia for Knee Arthroscopy Using Isobaric Bupivacaine and Levobupivacaine: Anesthetic and Neuroophthalmological Assessment. BioMed Research International, vol. 2014, Article ID 349034, 7 pages, 2014. doi: 10.1155/2014/349034.
  9. Sanansilp V., Trvate T., Chompubai P., Visalyaputra S., Suksopee P., Permpolprasert L. et al. Clinical characteristics of spinal levobupivacaine: hyperbaric compared with isobaric solution. Scientific World Journal. 2012; 2012:169076. doi: 10.1100/2012/169076. Epub 2012 Apr. 24.
  10. Lee Y.Y., Muchhal K., Chan C.K. Levobupivacaine versus racemic bupivacaine in spinal anaesthesia for urological surgery. Anaesth. Intensive Care. 2003; 31(6): 637-41.
  11. Gulec D., Karsli B., Ertugrul F., Bigat Z., Kayacan N. Intrathecal bupivacaine or levobupivacaine: which should be used for elderly patients? J. Int. Med. Res. 2014; 42(2): 376-85.
  12. Jindal R., Gupta M. Comparison of isobaric Ropivacaine and Levobupivacaine in patients undergoing lower abdominal surgery under spinal anesthesia. International Journal of Scientific Research and Education. 2016; 4(5): 5288-5293.
  13. Burke D., Kennedy S., Bannister J. Spinal anesthesia with 0.5% S(-)-bupivacaine for elective lower limb surgery. Reg. Anesth. Pain Med. 1999; 24(6): 519-23.
  14. Glaser C., Marhofer P., Zimpfer G., Heinz M.T., Sitzwohl C., Kapral S. et al. Levobupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth. Analg. 2002; 94(1): 194-8.
  15. Whiteside J.B., Wildsmith J.A.W. Spinal anaesthesia: an update. Continuing Education in Anaesthesia, Critical Care & Pain. 2005; 5(2): 37-40.
  16. McLeod G.A., Burke D. Levobupivacaine. Anaesthesia. 2001; 56: 331-341.
  17. Cuvas O., Basar H., Yeygel A., Turkyilmaz E., Sunay M.M. Spinal anesthesia for transurethral resection operations: levobupivacaine with or without fentanyl. Middle East J. Anaesthesiol. 2010; 20(4): 547-52.
  18. Fattorini F., Ricci Z., Rocco A., Romano R., Pascarella M.A., Pinto G. Levobupivacaine versus racemic bupivacaine for spinal anaesthesia in orthopaedic major surgery. Minerva Anestesiol. 2006; 72(7-8): 637-44.
  19. Singh G., Kelkar V., Kulkarni S., Nayak P., Udiavar A., Warkari T. Comprison of isobaric levobupivacaine 0.5% and isobaric ropivacaine 0.5% for spinal anaesthesia in lower limb surgeries. World Journal of Pharmaceutical and Medical Research. 2017; 3(1): 448-453.
  20. Mann A., Harper I., Brock S. Levobupivacaine for low-dose spinal anaesthesia. BJA. 2014; 112(2): 380.
  21. Naithani U., Malleshappa K., Pramod M. Comparison of Intrathecal Isobaric Levobupivacaine with Hyperbaric Bupivacaine in Spinal Anesthesia for Lower Limb. Orthopedic Surgeries. International Journal of Health Sciences and Research IJHSR. 2015; 5(10): 73-84.
  22. Mohan S., Saran J., Kashyap M. Comparative Study of 0.5% Levobupivacaine and 0.5% Levobupivacaine with Fentanyl in Transurethral Resection of Prostate. International Journal of Scientific Study. 2017; 4(10): 67-72.
  23. Ertugrul F., Bigat Z., Kayacan N., Karsli B. An unusually prolonged duration of spinal anaesthesia following 0.5% Levobupivacaine. J. Pak. Med. Assoc. 2012; 62(11): 1235-39.
  24. Lee Y.Y., Muchhal K., Chan C.K., Cheung A.S. Levobupivacaine and fentanyl for spinal anaesthesia: a randomized trial. Eur. J. Anaesthesiol. 2005; 22(12): 899-903.
  25. Erbay H.R., Ermumcu O., Hanci V., Atalay H. A comparison of spinal anesthesia with low-dose hyperbaric levobupivacaine and hyperbaric bupivacaine for transurethral surgery: a randomized controlled trial. Minerva Anestesiol. 2010; 76(12): 992-1001.
  26. Maniyar F., Trishala J., Praveen K.O. Spinal Anesthesia for Transurethral Resection of Prostate: Levobupivacaine with or without Fentanyl. Int. J. Anesth. Res. 2016; 4(11): 358-362.
  27. Casati A., Moizo E., Marchetti C., Vinciguerra F. A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth. Analg. 2004; 99(5): 1387-92.
  28. Alley E.A., Kopacz D.J., McDonald S.B., Liu S.S. Hyperbaric spinal levobupivacaine: a comparison to racemic bupivacaine in volunteers. Anesth. Analg. 2002; 94(1): 188-93.
  29. Zaric D., Pace N.L. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics (Review) Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003006.
  30. Gozdemir M., Muslu B., Sert H., Usta B., Demircioglu R.I., Kasikara H. Transient neurological symptoms after spinal anesthesia. Clin. Invest. Med. 2016; 39(6): 106-110.

Copyright (c) 2018 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies